Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TDP2 | O95551 | 1/20 | 0.33 |
| ▸ | NSD2 | O96028 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.33 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30499370 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TDP2NSD2HSP90AA1PAX8 | |
| SCHEMBL10753626 | 0.81 | NCEH1 (0.42) | ALDH1A1TDP2NSD2HSP90AA1PAX8 | |
| SCHEMBL338060 | 0.81 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL338178 | 0.79 | ALDH1A1 (0.41) | ALDH1A1CYP1A2 | |
| SCHEMBL1023210 | 0.79 | ALDH1A1 (0.41) | ALDH1A1TDP2NSD2HSP90AA1PAX8 | |
| SCHEMBL819186 | 0.77 | ALDH1A1 (0.42) | ALDH1A1NCEH1POLBCYP1A2 | |
| SCHEMBL31668870 | 0.77 | ALDH1A1 (0.42) | ALDH1A1NCEH1POLBCYP1A2 | |
| SCHEMBL29380074 | 0.77 | ALDH1A1 (0.42) | ALDH1A1HSP90AA1 | |
| SCHEMBL1590024 | 0.77 | ALDH1A1 (0.42) | ALDH1A1HSP90AA1 | |
| Ammonia Solution, Strong SCHEMBL3863207 | 0.77 | ALDH1A1 (0.39) | ALDH1A1TDP2NSD2HSP90AA1PAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016148649-A1 | FUNCTIONALIZED QUATERNARY AMMONIUM HALIDES AND USE THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-09-22 | — | — | WO | claimed |
| EP-2627172-A1 | AN ANTIMICROBIAL COMPOSITION | Agency For Science, Technology And Research (SG) | 2013-08-21 | — | — | EP | claimed |
| US-20130210881-A1 | ANTIMICROBIAL COMPOSITION | AGENCY FOR SCIENCE ,TECHNOLOGY AND RESEARCH (SG) | 2013-08-15 | — | — | US | claimed |
| WO-2012050531-A1 | AN ANTIMICROBIAL COMPOSITION | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-04-19 | — | — | WO | claimed |
| JP-2007502342-A | — | — | 2007-02-08 | — | — | JP | claimed |
| EP-1664167-A4 | THE POLYELECTROLYTE COMPOSITION FOR HUMIDITY SENSER, POLYELECTROLYTE INK AND PREPARATION METHOD OF POLYELECTROLYTE MEMBRANE FOR SENSOR BY INKJET PRINTING | HAEUN CHEMTEC CO LTD (KR) | 2006-09-20 | — | — | EP | claimed |
| EP-1664167-A1 | THE POLYELECTROLYTE COMPOSITION FOR HUMIDITY SENSER, POLYELECTROLYTE INK AND PREPARATION METHOD OF POLYELECTROLYTE MEMBRANE FOR SENSOR BY INKJET PRINTING | Haeun Chemtec Co. Ltd. (KR) | 2006-06-07 | — | — | EP | claimed |
| WO-2005014700-A1 | THE POLYELECTROLYTE COMPOSITION FOR HUMIDITY SENSER, POLYELECTROLYTE INK AND PREPARATION METHOD OF POLYELECTROLYTE MEMBRANE FOR SENSOR BY INKJET PRINTING | HAEUN CHEMTEC CO., LTD. (KR) | 2005-02-17 | — | — | WO | claimed |
| JP-55054381-A | — | — | None | — | — | JP | disclosed |
| CN-121045338-B | Cyclic peptide targeting CAIX and preparation method and application thereof | 原子高科股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-122056129-A | Method for manufacturing semiconductor device | 株式会社力森诺科 | 2026-05-15 | — | — | CN | disclosed |
| US-20260126453-A1 | Mass Spectrometry Kit Including a Cross-linked Antibody or Fragment Thereof | THE BINDING SITE GROUP LTD (GB) | 2026-05-07 | — | — | US | disclosed |
| EP-4675278-A2 | ASSAY FOR PLASMA CELL ASSOCIATED DISEASE | The Binding Site Group Limited (GB) | 2026-01-07 | — | — | EP | disclosed |
| US-12461108-B2 | Mass spectrometry kit including a cross-linked antibody or fragment thereof | THE BINDING SITE GROUP LIMITED (GB) | 2025-11-04 | — | — | US | disclosed |
| EP-0448078-A2 | Substituted amine derivatives having anti-hyperlipemia activity | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1991-09-25 | — | — | EP | disclosed |
| WO-1991009848-A1 | PYRIDINONES USEFUL AS ANTIATHEROSCLEROTIC AGENTS | THE UPJOHN COMPANY (US) | 1991-07-11 | — | — | WO | disclosed |
| WO-1991006626-A2 | TRIPLE HELIX FORMATION IN OLIGONUCLEOTIDE THERAPY | GILEAD SCIENCES, INC. (US) | 1991-05-16 | — | — | WO | disclosed |
| EP-0387769-A1 | Toner containing a diarylguanidine type compound for developing electrostatic images | CANON KABUSHIKI KAISHA (JP) | 1990-09-19 | — | — | EP | disclosed |
| EP-0010896-B1 | ORGANIC DIAMINE COMPOUNDS FOR USE AS ORAL HYPOGLYCEMIC AGENTS AND PHARMACEUTICAL COMPOSITIONS THEREOF | PFIZER INC. (US) | 1981-12-30 | — | — | EP | disclosed |
| JP-S5554381-A | ELECTROCHROMIC MATERIAL FOR DISPLAY DEVICE | HITACHI LTD | 1980-04-21 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260126453-A1 | Mass Spectrometry Kit Including a Cross-linked Antibody or Fragment Thereof | IGLV6-57, IGSF11, FCGR3B | ALDH1A1 2401/4885TDP2 3693/4885NSD2 2870/4885 |
| US-20130210881-A1 | ANTIMICROBIAL COMPOSITION | NOD2, MPO, NACA | ALDH1A1 4221/4885TDP2 2299/4885NSD2 3761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.